Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 159.14M | 71.31M | 234.20M | 201.30M | 77.03M |
| Total Depreciation and Amortization | 402.62M | 361.63M | 409.07M | 278.83M | 420.92M |
| Total Amortization of Deferred Charges | -- | 56.17M | -- | -- | -- |
| Total Other Non-Cash Items | 14.76M | 165.91M | -148.13M | -126.20M | 97.10M |
| Change in Net Operating Assets | -405.18M | 231.55M | 587.43M | 122.26M | -456.85M |
| Cash from Operations | 171.35M | 886.57M | 1.08B | 476.20M | 138.20M |
| Capital Expenditure | -153.39M | -256.57M | -181.78M | -171.59M | -145.36M |
| Sale of Property, Plant, and Equipment | 3.65M | 8.10M | -4.63M | 6.79M | 4.78M |
| Cash Acquisitions | -6.56M | 19.54M | -14.01M | -7.17M | 968.30K |
| Divestitures | 19.90M | 136.10M | 1.20M | 496.51M | 43.08M |
| Other Investing Activities | 22.49M | -34.23M | -42.56M | 22.63M | 22.31M |
| Cash from Investing | -113.91M | -127.06M | -241.79M | 347.18M | -74.22M |
| Total Debt Issued | 106.21M | -76.32M | 5.31M | -79.75M | 297.09M |
| Total Debt Repaid | -185.22M | -761.59M | -394.66M | -383.40M | -534.93M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00 | 0.00 | -375.82M | -- |
| Other Financing Activities | -59.78M | -127.27M | -87.74M | -25.07M | -51.82M |
| Cash from Financing | -146.05M | -1.03B | -524.50M | -901.29M | -314.45M |
| Foreign Exchange rate Adjustments | -23.61M | 54.14M | -13.59M | -8.31M | -4.90M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.22M | -215.20M | 302.69M | -86.23M | -255.36M |